Sinovac (Dalian) Vaccine Technology Co., Ltd.
Quick facts
Marketed products
- Investigational live attenuated varicella vaccine
- Mumps vaccine · Immunology / Infectious Disease
The mumps vaccine stimulates the immune system to produce antibodies and cellular immunity against the mumps virus, preventing infection and disease. - Varicella vaccine+TIV · Immunology
This combination vaccine stimulates immune responses against varicella-zoster virus and influenza virus through live attenuated or inactivated viral antigens.
Phase 3 pipeline
- diluent of lyophilized vaccine
- PROVARIX · Immunology / Infectious Disease
PROVARIX is a recombinant varicella-zoster virus (VZV) vaccine designed to prevent herpes zoster (shingles) and post-herpetic neuralgia in immunocompetent and immunocompromised populations. - Vaccine manufactured at commercialized scale · Immunology
This vaccine works by stimulating the body's immune system to produce a protective response against the SARS-CoV-2 virus.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: